Loading...
Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
BACKGROUND AND PURPOSE: We previously showed that nociceptin/orphanin FQ opioid peptide (NOP) receptor agonists attenuate the expression of levodopa‐induced dyskinesia in animal models of Parkinson's disease. We now investigate the efficacy of two novel, potent and chemically distinct NOP recep...
Na minha lista:
| Udgivet i: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5811622/ https://ncbi.nlm.nih.gov/pubmed/29232769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14123 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|